Natthaprang Nittayasoot

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Coronavirus Disease

Extracorporeal Membrane Oxygenation

Virtual Reality

Respiratory Failure

Top Venues

Tropical medicine and infectious disease

This page only lists publications with an associated author ORCID identifier.

Publications

Kanchanok Sirison, Natthaprang Nittayasoot, Ranida Techasuwanna, Nisachol Cetthakrikul, Repeepong Suphanchaimat
Cost-Effectiveness Analysis of COVID-19 Vaccine Booster Dose in the Thai Setting during the Period of Omicron Variant Predominance. Tropical medicine and infectious disease 8 (2) (2023)
Kanchanok Sirison, Natthaprang Nittayasoot, Ranida Techasuwanna, Nisachol Cetthakrikul, Repeepong Suphanchaimat
Cost-Effectiveness Analysis of COVID-19 Vaccine Booster Dose in the Thai Setting during the Period of Omicron Variant Predominance. Tropical medicine and infectious disease 8 (2) (2023)
Kanchanok Sirison, Natthaprang Nittayasoot, Ranida Techasuwanna, Nisachol Cetthakrikul, Repeepong Suphanchaimat
Cost-Effectiveness Analysis of COVID-19 Vaccine Booster Dose in the Thai Setting during the Period of Omicron Variant Predominance. Tropical medicine and infectious disease 8 (2) (2023)
Natthaprang Nittayasoot, Rapeepong Suphanchaimat, Panithee Thammawijaya, Chuleeporn Jiraphongsa, Taweesap Siraprapasiri, Kritchavat Ploddi, Chakkarat Pittayawonganon, Surakameth Mahasirimongkol, Piyanit Tharmaphornpilas
Real-World Effectiveness of COVID-19 Vaccines against Severe Outcomes during the Period of Omicron Predominance in Thailand: A Test-Negative Nationwide Case-Control Study. Vaccines 10 (12) (2022)
Natthaprang Nittayasoot, Rapeepong Suphanchaimat, Panithee Thammawijaya, Chuleeporn Jiraphongsa, Taweesap Siraprapasiri, Kritchavat Ploddi, Chakkarat Pittayawonganon, Surakameth Mahasirimongkol, Piyanit Tharmaphornpilas
Real-World Effectiveness of COVID-19 Vaccines against Severe Outcomes during the Period of Omicron Predominance in Thailand: A Test-Negative Nationwide Case-Control Study. Vaccines 10 (12) (2022)
Natthaprang Nittayasoot, Rapeepong Suphanchaimat, Panithee Thammawijaya, Chuleeporn Jiraphongsa, Taweesap Siraprapasiri, Kritchavat Ploddi, Chakkarat Pittayawonganon, Surakameth Mahasirimongkol, Piyanit Tharmaphornpilas
Real-World Effectiveness of COVID-19 Vaccines against Severe Outcomes during the Period of Omicron Predominance in Thailand: A Test-Negative Nationwide Case-Control Study. Vaccines 10 (12) (2022)
Natthaprang Nittayasoot, Rapeepong Suphanchaimat, Panithee Thammawijaya, Chuleeporn Jiraphongsa, Taweesap Siraprapasiri, Kritchavat Ploddi, Chakkarat Pittayawonganon, Surakameth Mahasirimongkol, Piyanit Tharmaphornpilas
Real-World Effectiveness of COVID-19 Vaccines against Severe Outcomes during the Period of Omicron Predominance in Thailand: A Test-Negative Nationwide Case-Control Study. Vaccines 10 (12) (2022)